Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study

OBJECTIVES: Definition of the optimal pneumococcal vaccine strategy in HIV-infected adults is still under evaluation. We aimed to compare immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine (PCV13) versus the 23-valent polysaccharide vaccine (PPSV23) in HIV-infected adults. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombardi, Francesca, Belmonti, Simone, Fabbiani, Massimiliano, Morandi, Matteo, Rossetti, Barbara, Tordini, Giacinta, Cauda, Roberto, De Luca, Andrea, Di Giambenedetto, Simona, Montagnani, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892598/
https://www.ncbi.nlm.nih.gov/pubmed/27258647
http://dx.doi.org/10.1371/journal.pone.0156523

Ejemplares similares

Ejemplares similares